Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas - PubMed (original) (raw)

The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancer.

McDaid WJ, Wilson L, Adderley H, Martinez-Lopez A, Baker MJ, Searle J, Ginn L, Budden T, Aldea M, Marinello A, Aredo JV, Viros A, Besse B, Wakelee HA, Blackhall F, Castillo-Lluva S, Lindsay CR, Malliri A. McDaid WJ, et al. Mol Cancer. 2024 Nov 12;23(1):253. doi: 10.1186/s12943-024-02157-x. Mol Cancer. 2024. PMID: 39533328 Free PMC article.

Blood biomarkers to predict the efficacy of neoadjuvant chemo-immunotherapy in non-small cell lung cancer patients.

Pan Y, Jin X, Hong J, Wang Y, Xu H, Lin J, Zhang Y, Yin K, Zhang J, Inamura K, Liu D, Li F, Zeng J. Pan Y, et al. Transl Lung Cancer Res. 2024 Oct 31;13(10):2773-2786. doi: 10.21037/tlcr-24-717. Epub 2024 Oct 23. Transl Lung Cancer Res. 2024. PMID: 39507016 Free PMC article.

Gene-based burden tests of rare germline variants identify six cancer susceptibility genes.

Ivarsdottir EV, Gudmundsson J, Tragante V, Sveinbjornsson G, Kristmundsdottir S, Stacey SN, Halldorsson GH, Magnusson MI, Oddsson A, Walters GB, Sigurdsson A, Saevarsdottir S, Beyter D, Thorleifsson G, Halldorsson BV, Melsted P, Stefansson H, Jonsdottir I, Sørensen E, Pedersen OB, Erikstrup C, Bøgsted M, Pøhl M, Røder A, Stroomberg HV, Gögenur I, Hillingsø J, Bojesen SE, Lassen U, Høgdall E, Ullum H, Brunak S, Ostrowski SR; DBDS Genomic Consortium; Sonderby IE, Frei O, Djurovic S, Havdahl A, Moller P, Dominguez-Valentin M, Haavik J, Andreassen OA, Hovig E, Agnarsson BA, Hilmarsson R, Johannsson OT, Valdimarsson T, Jonsson S, Moller PH, Olafsson JH, Sigurgeirsson B, Jonasson JG, Tryggvason G, Holm H, Sulem P, Rafnar T, Gudbjartsson DF, Stefansson K. Ivarsdottir EV, et al. Nat Genet. 2024 Nov;56(11):2422-2433. doi: 10.1038/s41588-024-01966-6. Epub 2024 Oct 29. Nat Genet. 2024. PMID: 39472694